Office of Surveillance and Epidemiology (OSE) - Programs and Activities

Office of Surveillance and Epidemiology (OSE) Home

• Patient Labeling and Risk Communication
• Medication Guides
• Drug Safety and Risk Management (DSaRM) Advisory Committee gained full committee status on June 1, 2002.
  • Meeting, member, and charter information for the DSaRM  Advisory Committee.  
• MedWatch  MedWatch, the FDA Safety Information and Adverse Event Reporting Program, provides safety information for all FDA-regulated medical products (drugs, biologics, medical devices, and dietary supplements) to both healthcare professionals and the general public. 
  • MedWatch Partners work with FDA to help keep their members informed about medical product safety information